Acceso gestor editorial

Revista Angiología H0063
Resumen| PDF


Guía clínica. Tratamiento endovascular de la patología obstructiva aortoiliaca

Publicado: 2021-05-05

Logo Descargas   Número de descargas: 36498      Logo Visitas   Número de visitas: 936      Citas   Citas: 0


Palabras Clave:

Baker JD. Physiologic studies to document severity of aortoiliac occlusive disease. En: Ernst CB, Stanley JC, editores. Current Therapy in Vascular Surgery. 4.a ed. St. Louis, Mo:
Mosby-Year Book, Inc; 2001.
Dormandy JA, Rutherford RB. Management of peripheral arterial disease. TransAtlantic Inter-Society Consensus. J Vasc Surg. 2000;31:1—296.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1—75.
Hirsch AT, Haskal ZV, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA Guidelines for the management of peripheral arterial disease (lower extremity, renal mesenteric
and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions,
Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). American College of CardiologyWeb Site. Disponible en:
Schneider PA. Endovascular or open surgery for aortoiliac occlusive disease? Cardiovasc Surg. 2002;10:378—82.
Gómez-Ruiz FT, Plaza-Martínez A, Díaz-López M, Riera-Vázquez R. Coste de los procedimientos endovasculares desobliterantes del sector aorto-iliaco. Cirugía Endovascular del Sector Aorto-iliaco. Barcelona: J. Uriach; 2001. p. 279—–95.
Plaza-Martínez A, Gómez-Ruiz FT, Lozano-Vilardell P, Díaz-López M, Riera-Vázquez R, Cordobés-Gual J, et al. Coste-utilidad y calidad de vida del tratamiento endovascular en el sector iliaco. Arch Cir Vasc. 2002;XI:3—8.
Fontcuberta J, Flores A, Langsfeld M, Orgaz A, Cuenca R, Criado E, et al. Screening algorithm for aortoiliac occlusive using duplex ultrasonography-acquired velocity spectra from the distal external iliac artery. Vascular. 2005;13:162—72.
AbuRahma AF, Jarret K, Hayes DJ. Clinical implications of power Doppler three-tridimensional ultrasonography. Vascular. 2004;12:293—300.
Willmann JK, Baumert B, Schertler T, Wildermuth S, Pfammatter T, Verdun FR, et al. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparasion with digital subtration angiography. Radiology. 2005;236:1083—93.
Rankin SC. Spiral CT vascular applications. Eur J Radiol. 1998;28:18—30.
Goyen M, Edelman M, Perreault P, O’Riordan E, Bertoni H, Taylor J, et al. MR angiography of aortoilac occlusive disease: a phase III study of de safety and effectiveness of the
blood-pool contrast agent MS-325. Radiology. 2005;236:825—33.
Martin ML, Tay KH, Flak B, Fry PD, Doyle DL, Taylor DC, et al. Multidetector CT angiography of the aortoiliac system and lower extremities: a prospective comparison with digital subtraction angiography. AJR Am J Roentgenol. 2003;180:1085—91.
Rieker C, Duber C, Neufang A, Pitton M, Schweden F, Thelen M. CT angiography versus intraarterial digital subtraction angiography for assessment of aortoiliac occlussive disease. AJR Am J Roentgenol. 1997;169:1133—8.
Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstructions: description of a new technique and a preliminary report of its application. Circulation. 1964;30:654—9.
Standards of practice committee of the society of cardiovascular and interventional radiology. Guidelines for percutaneus transluminal angioplasty. Radiology. 1990;177:619—26.
Kumpe DA, Zwerdlinger S, Griffin DJ. Blue digit syndrome: treatment with percutaneous transluminal angioplasty. Radiology. 1988;166:37—44.
Burke DR. Percutaneous ballon angioplasty. En: Cope C, editor. Atlas of interventional radiology. Filadelfia: J.B. Lippincott Company; 1990. Cap. 7.
Schwarten DE, Tadavarty SM, Casta˜neda-Zu˜niga WR. Aortic, iliac, and peripheral angioplasty. En: Casta˜neda-Zu˜niga WR, Tadavarty SM, editores. Interventional radiology, 1, 2.a ed.
Baltimore: Williams & Wilkins; 1992. p. 391.
Rutherford RB. Standards for evaluating results of interventional therapy for peripheral vascular disease. Circulation. 1991;83(2 Suppl):I6—11.
Rutherford RB, Becker GJ. Standards for evaluating and reporting the results of surgical and percutaneus therapy for peripheral arterial disease. Radiology. 1991;181:277—81.
Rutherford RB, Flanigan DP, Gupta SK, Johnston KW, Karmody A, Whittemore AD, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg. 1986;4:80—94.
Ahn SS, Rutherford RB, Becker GJ, Comerota AJ, Johnston KW, McClean GK, et al. Reporting standards for lower extremity arterial endovascular procedures. J Vasc Surg. 1993;17:1103—7.
Medina JG. Indicaciones de la angioplastia. In: Radiología Intervencionista. Angioplastia en la AOP. Madrid: Marban Libros, S.L; 1997. p. 49—52.
Pentecost MJ, Criqui MH, Dorros G, Goldstone J, Johnston KW, Martin EC, et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower
extremity vessels. Circulation. 1994;89:511—31.
Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1 Pt 2):S1—296.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral
Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5—67.
Dotter CT. Transluminally placed coil-spring endarterial tube grafts, long term patency in canine popliteal artery. Invest Radiol. 1969;4:329—32.
Ros Die E, Salmerón Febres LM, Fernández Quesada F, Linares Palomino P. Angioplastia con stent. En: Valentín Fernández Valenzuela, editor. Cirugía Endovascular del sector
aortoiliaco. Barcelona: J. Uriach & Cía, S.A; 2001. p. 181—9.
Cambria RA, Farooq MM, Mewissen MW, Freischlag JA, Seasbrook GR, Crain MR, et al. Endovascular therapy of iliac arteries: routine application of intraluminal stents doesn’t
improve clinical patency. Ann Vasc Surg. 1999;13:599—605.
Volodos’ NL, Shekhanin VE, Karpovich IP, Troian VI, Gur’ev IuA. Self-fixing synthetic prosthesis for endoprosthetics of the vessels. Vestn Khir. 1986;137:123—5.
Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysm. Ann Vasc Surg. 1991;5:491—9.
Gutiérrez Alonso V, González Fajardo JA, Carrera Díaz S, Vaquero Puerta C. Uso de stent cubierto en patología iliaca. En: Valentín Fernández Valenzuela, editor. Cirugía Endovascular
del sector aortoiliaco. Barcelona: J. Uriach & Cía, S.A.; 2001. p. 209—15.
Weaver FA, Comerota AJ, Youngblood M, Froehlich J, Hosking JD, Papanicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery
occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg. 1996;24:513—23.
Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral
Arterial Surgery (TOPAS) Investigators. N Engl J Med. 1998;338:1105—11.
Thrombolysis in the management of lower limb peripheral arterial occlusion-a consensus document. Working Party on Thrombolysis in the Management of Limb Ischemia. Am J Cardiol.
Ballaed JI, Sparks SR, Taylor FC. Complications of iliac artery stent deployment. J Vasc Surg. 1996;24:545—55.
Bosch JL, Hinink MGM. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997;204:87—96.
Derom A, Vermassen F, Ongena K. PTA and stenting after previous aortoiliac endarterectomy. Eur J Vasc Endovasc Surg. 2001;22:130—3.
Vaquero C. Procedimientos endovasculares. Gráficas Andrés Martín S.A; 2006.
Henry M, Amor M, Ethevenot G. Palmaz stent in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology. 1995;197:17—74.
Johnston KW. lliac arteries: Reanalysis of results of balloon angioplasty. Radiology. 1993;166:207—12.
Katz SG, Kohl RD, Yellin A. Iliac angioplasty as a prelude to distal arterial bypass. J Am Coll Surg. 1994;179:577—82.
Krajcer Z, Sioco G, Reynols T. Comparison of Wallgrafth and Wallstent for treatment of complex iliac artery stenosis and occlusion. Preliminary results of a prospective randomized study. Tex Herart Inst J. 1997;24:193—9.
Murphy TP, Webb MS, Lambiase RE. Percutaneous revascularization of complex iliac artery stenoses and occlusions with use of wallstents: three-year experience. J Vasc Interv Radiol. 1996;7:21—7.
Murray JG, Apthorp LA, Wilkins RA. Long-segment (>10 cm) femoropopliteal angioplasty improved technical success and long-term patency. Radiology. 1995;195:158—62.
Nawaz S, Cleveland T, Gaines P, Beard J, Chan P. Aortoiliac stenting, determinants of clinical outcome. Eur J Vasc Endovasc Surg. 1999;117:351—9.
Palmaz JC, Laborde JC, Rivera FJ, Encarnacion CE, Lutz JD, Moss JG. Stenting of the iliac arteries with the Palmaz stent: Experience from multicenter trial. Cardiovasc Intervent
Radiol. 1992;190:199—202.
Saha S, Gibson M, Torrie EPH, Magee TR, Galland RB. Stenting for localised arterial stenoses in the aorto-iliac segment. Eur J Vasc Endovasc Surg. 2001;22:37—40.
Strecker EP, Boos IBL, Hagen B. Flexible tantalum stents for the treatment of iliac artery lesions: long-term patency, complications, and risk factors. Radiology. 1996;199:641—7.
Tepe G, Duda SH, Hanke H, Schilze S, Hagmeier S, Bruck B, et al. Covered stents for prevention of restenosis. Experimental and clinical results with different stent designs. Invest
Radiol. 1996;31:223—9.
Tetteroo E, Van der Graaf Y, Bosch JL, Van Engelen AD, Hunink MG, Eikelboom BC, et al. Randomised comparison of primary stent placement versus primary angioplasty followed
by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998;351:1153—9.
Rutherford RB, Baker JD, Ernest C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg.
Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199—202.
Singh H, Cardella JF, Cole PE, Grassi CJ, McCowan TC, Swan TL, et al. Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol. 2002;13:1—6.
Society of Interventional Radiology Standards of Practice Committee. Guidelines for establishing a quality assurance program in vascular and interventional radiology. J Vasc Interv
Radiol. 2003;14(9 Pt 2):S203—7.
Kent KC, Moscucci M, Mansour KA, Dimattia S, Gallagher S, Kuntz R, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20:905—13.
Cadman PJ. Case report: femoral nerve palsy complicating femoral artery puncture and intra-arterial thrombolysis. Clin Radiol. 1995;50:345—6.
Hessel SL, Adams DF, Abrams HL. Complications of angiography. Radiology. 2001;138:273—81.
Ziakas A, Klinke P, Mildenberger R, Fretz E, Willians M, Della Siega A, et al. Comparison of the radial and femoral approaches in percutaneous coronary intervention for acute
myocardial infarction. Am J Cardiol. 2003;91:598—600.
Gaspar MR, Yellin AE. Femoral artery occlusion caused by percutaneous angiography mechanisms and management. Acta Chirurgica Belgica. 1977;3:323—8.
Kim D, Orron DE, Skillman JJ, Kent CK, Porter DH, Schalm BW, et al. Role of superficial femoral artery puncture in the development of pseudoaneuysm and arteriovenous fistula
complicating percutaneous transfemoral cardiac catheterizacion. Catheteriz Cardiovasc Diag. 1992;25:91—7.
Babu SC, Piccorelli GO, Shah PPM, Atein JH, Clauss RH. Incidence and results of arterial complication among 16350 patients undergoing cardiac catheterization. J Vasc Surg.
Rapoport S, Sniderman KW, Proto MH, Ross GR. Pseudoaneurysm: a complication of faulty technique in femoral artery puncture. Radiology. 1985;154:529—30.
Hood DB, Mattos MA, Douglas MG, Barkmeier LD, Hodgson KJ, Ramsey DE, et al. Determinants of success of color-flow duplex-guided compression repair of femoral
pseudoaneurysms. Surgery. 1996;120:585—90.
Sackett WR, Taylor SM, Coffey CB, Viers KD, Langan EM, Cull DL, et al. Ultrasound-guided thrombin injection of iatrogenic femoral pseudoaneurysms: a prospective analysis. Am
Surgeon. 2000;66:937—42.
Mooney MR, Ellis SG, Gershony G, Yehyawi KJ, Kummer B, Lowrie M. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the duet vascular closure device. Catheteriz Cardiovasc Diagn. 2000;50:96—102.
Dangas G, Meharan R, Kokolis S, Feldman D, Satler L, Pichard AD, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual
compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001;38:638—44.
Kline RM, Hertzer NR, Beven EG, Krajewski LP, O’Hara PJ. Surgical treatment of brachial artery injuries after cardiac catheterization. J Vasc Surg. 1990;12:20—4.
Kennedy AM, Grocott M, Schwartz MS, Modarres H, Scott M, Schon F. Median nerve injury: an underrecognised complication of brachial artery cardiac catheterisation? J Neurol
Neurosurg Psychiatry. 1997;63:542—6.
Gacliardi JM, Batt M, Avril G, Declemy S, Hassen-Khodja R, Daune B, et al. Neurological complications of axilary and brachial catheter arteriography in atherosclerotic patients:
predictive factors. Ann Vasc Surg. 1990;4:546—9.
Silva JA, Ramee SR, Collins TJ, Jenkins JS, Lansky AJ,Ansel GM, et al. Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and
six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators. Cathet Cardiovasc Diagn. 1998;45:386—93.
Ansel GM, George BS, Botti CF, McNamara TO, Jenkins JS, Ramee SR, et al. Rheolitic trombectomy in the management of limb ischemia: 30-day results from a multicenter registry.
J Endovasc Ther. 2002;9:395—402.
Ouriel K, Gray BH, Clair DG, Olin JW. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol. 2000;11:295—8.
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg. 1994;220:251—6.
Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol. 1991;157:49—58.
Morcos SK. Contrast media-induced nephrotoxicity- questions and answers. Br J Radiol. 1998;71:357—65.
Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J
Med. 1994;331:1416—20.
Díaz Sandoval LJ, Kodowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol. 2002;89:356—8.
Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxicity in high-risk patients study iso-osmolar and low-osmolar nonionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491—9.
Townsend RR, Cohen DL, Fatholi R, Swan SK, Davies BE, Bensel K, et al. Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. Am J Kidney Dis.
Caridi JG, Stavropoulos SW, Hawkins Jr IF. CO2 digital subtraction angiography for renal artery angioplasty in high-risk patients. AJR Am J Roentgenol. 1999;173:1551—6.
Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1000 cases. J Am Coll Cardiol. 1998;32:1861—5.
Warkenin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated
heparin. N Engl J Med. 1995;332:1330—5.
Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, et al. Bivalirudin and provisional glycoprotein IIb/IIa blockade compared with heparin and planned
glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003;289:853—63.
Feldman T, Moss J, Teplinsky K, Carroll JD. Cardiac catheterization in patient with history of allergy to local anesthetics. Cathet Cardiovasc Diagn. 1990;20:165—7.
Stewart WJ, McSweeney SM, Kellett MA, Faxon DP, Ryan TJ. Increased risk of severe protamine reactions in NPH insulindependent diabetics undergoing cardiac catheterization.
Circulation. 1984;70:788—92.
Warshaw EM. Latex allergy. Skin Med. 2003;2:359—66.
Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major
vascular surgery. Ann Intern Med. 1989;110:859—66.
Hoffer EK, Bloch RD. Percutaneous arterial closure devices. J Vasc Interv Radiol. 2003;14:865—85.
Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Catheteriz Cardiovasc Interv. 2001;52:3—7.
Cura FA, Kapadia SR, L’Allier PL, Schneider JP, Kreindel MS, Silver MJ, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol. 2000;86:780—2.
Silber S, Bjorvik A, Muhling H, Rosch A. Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times. Cathet Cardiovasc Diagn. 1998;43:421—7.
Kresowik T, Khoury M, Miller BV, Winniford MD, Shamma AR, Sharp WJ, et al. A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg. 1991;13:328—36.
Eidt JF, Habibipour S, Saucedo JF, McKee J, Southern F, Barone GW, et al. Surgical complications from hemostatic puncture closure devices. Am J Surg. 1999;178:511—6.
Mettler Jr FA, Koenig TR, Wagner LK, Kelsey CA. Radiation injuries after fluoroscopic procedures. Semin Ultrasound CT MR. 2002;23:428—42.
Cardella JF, Miller DL, Cole PE, Patricia E, Lewis CA, Society of Interventional Radiology. Society of Interventional Radiology position statement on radiation safety. J Vasc Interv Radiol. 2003;14(9 Pt 2):S387.
Schürmann K, Mahnken A, Meyer J, Haage P, Chalabi K, Peters I, et al. Long-term results 10 years after iliac arterial stent placement. Radiology. 2002;224:731—8.
ACC/AHA 2005 practice Guidelines for the Management of Patients With Peripheral Arterial Disease. Circulation. 2006;113:1474—547.
100. Becquemin JP, Allaire E, Qvarfordt P, Desgranges P, Kobeiter H, Melliére D. Surgical transluminal iliac angioplasty with selective stenting: long-term results assessed by means of duplex scanning. J Vasc Surg. 1999;29:422—9.
101. Back MR, Novotney M, Roth SM, ElkinsD, Farber S, Cuthbertson D, et al. Utility of duplex surveillance following iliac artery angioplasty and primary stenting. J Endovasc Ther.
102. Tratamiento endovascular de la patologia arterial en los MMII. Documentos de base de terapéutica endovascular (preliminar). LII Congreso de la SEACV. Madrid, junio 2006.
103. Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Nagvi TZ, American Society of Echocardiography; Society for Vascular Medicine and Biology. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11:183—200.
104. Aracil E, Vila R, De Benito L, Miralles M. Guía básica del seguimiento no invasivo de la cirugía arterial. Guías prácticas de exploración del CDVNI de la SEACV. Angiología. 2001;2:89—110.
105. Martí X. Papel de la cartografía con ecodoppler en la toma de decisiones terapéuticas en la isquemia crítica de los miembros inferiores. Angiología. 2004;56:433—43.
106. Myers K, Clough A. Making sense of vascular ultrasound: a hands-on guide. Arnold Publishers; 2004.
107. Krebs C, Giyanoni V, Eisenberg R. Doppler color. Madrid: Marban libros; 2004.
108. Funovics MA, Lackner B, Cejna M, Peloschek P, Sailer J, Philipp MO, et al. Predictors of long-term results after treatment of iliac artery obliteration by transluminal angioplasty
and stent deployment. Cardiovasc Intervent Radiol. 2002;25:397— 402.
109. Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B
and C iliac lesions. J Vasc Surg. 2003;38:272—8.
110. Kudo T, Rigberg DA, Reil TD, Chandra FA, Ahn SS. The influence of the ipsilateral superficial femoral artery on iliac angioplasty. Ann Vasc Surg. 2006;20:502—11.
111. Schünemann HJ, Cook D, Grimshaw J, Liberati A, Heffner J, Tapson V, et al. Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference
on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):688S—96S.
112. Heart Protection Study Collaborative Group. MCR/BHF Heart Protection Study of cholesterol lowering with simvastatine in 20,536 high risk individuals: a randomised placebo-controlled
trial. Lancet. 2002;360:7—22.
113. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.The Heart
Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145—53.
114. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)–summary of recommendations. J Vasc Interv Radiol. 2006;17:1383—97.
115. Whatling PJ, Gibson M, Torrie EP, Magee TR, Galland RB. Iliac occlusions: stenting or crossover grafting? An examination of patency and cost. Eur J Vasc Endovasc Surg. 2000;20:36—40.
116. De Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, Hunink MG. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology. 2002;222:25—36.
117. Bosch JL, Haaring C, Meyerovitz MF, Cullen KA, Hunink MG. Costeffectiveness of percutaneous treatment of iliac artery occlusive disease in the United States. AJR Am J Roentgenol.

Artículos más populares

Originales: Resultado funcional y mortalidad en pacientes ancianos con amputación mayor de extremidad inferior

Introducción y objetivos: los objetivos de este tr...

Publicado: 2022-03-05

Originales: Ayudando a la toma de decisiones en el diagnóstico, tratamiento y seguimiento de úlceras de etiología vascular mediante el empleo de una aplicación móvil

Introducción y objetivo: los sistemas de ayuda a l...

Publicado: 2022-10-10

Originales: Experiencia y factores perioperatorios que afectan a los resultados en isquemia mesentérica aguda. Resultados de un hospital terciario chileno

Introducción y objetivo: la isquemia mesentérica e...

Publicado: 2023-07-05

Una cookie o galleta informática es un pequeño archivo de información que se guarda en su navegador cada vez que visita nuestra página web. La utilidad de las cookies es guardar el historial de su actividad en nuestra página web, de manera que, cuando la visite nuevamente, ésta pueda identificarle y configurar el contenido de la misma en base a sus hábitos de navegación, identidad y preferencias. Las cookies pueden ser aceptadas, rechazadas, bloqueadas y borradas, según desee. Ello podrá hacerlo mediante las opciones disponibles en la presente ventana o a través de la configuración de su navegador, según el caso. En caso de que rechace las cookies no podremos asegurarle el correcto funcionamiento de las distintas funcionalidades de nuestra página web. Más información en el apartado “POLÍTICA DE COOKIES” de nuestra página web.